Showing results (1471-1480 of 1,508) with videos related to
Sort By:
Pageof 151
HIV Medicine|June 24, 2022
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia-Pacific regionDyna Khuon, Dhanushi Rupasinghe, Vonthanak Saphonn, et al.The Journal of Infection|September 13, 2020
Fecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response predictionHye Seong, Sang Kil Lee, Jae Hee Cheon, et al.Blood Reviews|November 28, 2023
From microscope to micropixels: A rapid review of artificial intelligence for the peripheral blood filmBingwen Eugene Fan, Bryan Song Jun Yong, Ruiqi Li, et al.Plos One|September 4, 2014
Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational databaseDavid Charles Boettiger, Stephen Kerr, Rossana Ditangco, et al.Journal of the International AIDS Society|March 30, 2019
Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIVStephane Wen-Wei Ku, Awachana Jiamsakul, Kedar Joshi, et al.Immunity & Ageing : I & A|July 31, 2024
Overcoming the age-dependent SARS-CoV-2 vaccine response through hybrid immunity: analysis of humoral and cellular immunity with mass cytometry profilingZayakhuu Gerelkhuu, Sehee Park, Kyoung Hwa Lee, et al.Antiviral Therapy|April 12, 2021
Treatment modification after second-line failure among people living with HIV in the Asia-PacificAwachana Jiamsakul, Iskandar Azwa, Fujie Zhang, et al.AIDS Research and Human Retroviruses|September 29, 2015
Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHODSu Jin Jeong, Claire Italiano, Romanee Chaiwarith, et al.Microbiology Spectrum|October 17, 2022
Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding DomainBeomki Lee, Jae-Hoon Ko, Kyoung Hwa Lee, et al.Journal of Hepatology|January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levelsMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.Pageof 151